Acute exacerbation of chronic hepatitis B during thalidomide therapy for multiple myeloma: A case report

Korean Journal of Internal Medicine

Volumn 19, Issue 3, 2004, Pages 196-198

  Bang, Soo Mee ^a   Kim, Sun Suk ^a   Park, Se Hoon ^a   Ahn, Jeong Yeal ^a   Cho, Eun Kyung ^a   Shin, Dong Bok ^a   Lee, Jae Hoon ^a  

^a Gachon University   (South Korea)

Author keywords

Chronic hepatitis B; Multiple myeloma; Thalidomide

Indexed keywords

LAMIVUDINE; THALIDOMIDE; VIRUS DNA; ANGIOGENESIS INHIBITOR;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CASE REPORT; CHRONIC HEPATITIS; DISEASE EXACERBATION; DIZZINESS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAUNDICE; KLEBSIELLA PNEUMONIAE; LIVER TOXICITY; MALE; MULTIPLE MYELOMA; SEPTIC SHOCK; ENTEROBACTER INFECTION; MICROBIOLOGY; MIDDLE AGED;

ANGIOGENESIS INHIBITORS; HEPATITIS B, CHRONIC; HUMANS; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SHOCK, SEPTIC; THALIDOMIDE;

EID: 16544375784     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2004.19.3.196     Document Type: Article

References (10)

1. Thomas DA, Kantarjian HM. Current role of thalidomide in cancer treatment. Curr Opin Oncol 12:564-573, 2000
2. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B. Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565-1571, 1999
3. Desikan RK, Jagannath S. Therapeutic dilemmas with thalidomide in multiple myeloma: case discussions. Semin Oncol 28:593-596, 2001
4. Joo KR, Bang S, Song B, Yoon KH, Joo YH, Yang S, Kim KR, Chung Y, Lee YS, Suh DJ. Hepatitis B viral markers of Korean adults in the late 1990s: survey data of 70,437 health screenees. Korean J Gatroenterol 33:642-652, 1999
5. Lau GK, Liang R, Chiu EK, Lee CK, Lam SK. Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant 19:795-799, 1997
6. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G. Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173:699-703, 1991
7. Haslett PA, Corral LG, Albert M, Kaplan G. Thalidomide co-stimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med 187:1885-1892, 1998
8. Fowler R, Imrie K. Thalidomide-associated hepatitis: a case report. Am J Hematol 66:300-302, 2001
9. Raufman JP, Lamps LW. Thalidomide-induced normalization of serum ALT levels in a patient with hepatitis C. Am J Gastroenterol 96:3209-3211, 2001
10. Curley MJ, Hussein SA, Hassoun PM. Disseminated herpes simplex virus and varicella zoster virus co-infection in a patient taking thalidomide for a relapsed multiple myeloma. J Clin Microbiol 40: 2302-2304, 2002